Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic.

Spyridon GkalpakiotisMartina KojanováJorga FialováPetra CetkovskáVladimír VaškůYvetta VantuchováAlena MachovcováPetra GkalpakiotiPavla HrdáPetr Arenberger

Published in: Dermatology and therapy (2023)

LIBERO-CZ confirms the fast onset and high clearance rates of brodalumab in real life in both biologic-naïve and biologic-experienced patients.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
chronic kidney disease
healthcare
prognostic factors
physical activity
early onset
high intensity